Transscleral photodynamic therapy with a chlorin e6: An experimental study of exposure parameters and therapeutic window
TSPDT with chlorin e6 enables selective targeting of intraocular pathological tissues while preserving scleral and retinal integrity. Defining the therapeutic window and using real-time thermal monitoring enhances treatment safety. These findings lay a foundation for clinical protocols for uveal melanoma and other intraocular tumors.
Authors
- V. G. Gvazava (ORCID: https://orcid.org/0000-0002-2765-0332)
- Sergey Vorobyev
- Elena V. Samkovich
- Sergey B. Shevchenko
- Alexander A. Ivanov
- Irina E. Panova
- Elizaveta A. Masian
- Elizaveta S. Kalashnikova
- Ernest V. Boiko
- Alexandra E. Kim
Institutions
- St Petersburg University (RU)
- Morpho (United States) (US)
- Saint-Petersburg Medico-Social Institute (RU)
- Institute of Experimental Medicine (RU)
- Intersectoral Research and Technology Complex Eye Microsurgery (RU)
- North-Western State Medical University named after I.I. Mechnikov (RU)
Publication Details
- Journal
- PLoS ONE
- Published
- 2026-01-28
- DOI
- https://doi.org/10.1371/journal.pone.0341058
- Primary Topic
- Photodynamic Therapy Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Russian Science Foundation